BRPI0920124A2 - produto farmacêutico para aumentar a dose de vacina contra alergia - Google Patents

produto farmacêutico para aumentar a dose de vacina contra alergia

Info

Publication number
BRPI0920124A2
BRPI0920124A2 BRPI0920124A BRPI0920124A BRPI0920124A2 BR PI0920124 A2 BRPI0920124 A2 BR PI0920124A2 BR PI0920124 A BRPI0920124 A BR PI0920124A BR PI0920124 A BRPI0920124 A BR PI0920124A BR PI0920124 A2 BRPI0920124 A2 BR PI0920124A2
Authority
BR
Brazil
Prior art keywords
increase
pharmaceutical product
vaccine dose
allergy vaccine
allergy
Prior art date
Application number
BRPI0920124A
Other languages
English (en)
Inventor
Elke Gunther Wüstenberg
Henrik Hugo Jacobi
Lise Lund Maerkedahl
Original Assignee
Alk Abelló As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alk Abelló As filed Critical Alk Abelló As
Publication of BRPI0920124A2 publication Critical patent/BRPI0920124A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI0920124A 2008-10-15 2009-10-15 produto farmacêutico para aumentar a dose de vacina contra alergia BRPI0920124A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP08166707 2008-10-15
DKPA200801452 2008-10-17
DKPA200801831 2008-12-22
DKPA200900587 2009-05-07
PCT/EP2009/063489 WO2010043675A1 (en) 2008-10-15 2009-10-15 Pharmaceutical product for up-dosing of allergy vaccine

Publications (1)

Publication Number Publication Date
BRPI0920124A2 true BRPI0920124A2 (pt) 2015-12-22

Family

ID=41381747

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0920124A BRPI0920124A2 (pt) 2008-10-15 2009-10-15 produto farmacêutico para aumentar a dose de vacina contra alergia

Country Status (10)

Country Link
US (1) US8491911B2 (pt)
EP (1) EP2358388A1 (pt)
JP (1) JP2012505856A (pt)
CN (1) CN102186501A (pt)
AU (1) AU2009305406A1 (pt)
BR (1) BRPI0920124A2 (pt)
CA (1) CA2739557A1 (pt)
EA (1) EA201170569A1 (pt)
MX (1) MX2011003752A (pt)
WO (1) WO2010043675A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2593778C3 (ru) 2010-06-03 2020-12-21 Альк-Абелло А/С Фармацевтический продукт, содержащий экстракт(ы) аллергена клещей, и способ его получения
AU2012392291B2 (en) * 2012-10-19 2017-12-07 Hal Allergy Holding B.V. Compositions for immunotherapy
CN108265065B (zh) * 2016-12-31 2021-04-27 江苏众红生物工程创药研究院有限公司 一种重组黄花蒿1类变应原蛋白及其应用
US11524019B2 (en) 2017-08-21 2022-12-13 Glycom A/S Synthetic composition for reducing allergy symptoms
EP4228688A1 (en) 2020-10-14 2023-08-23 Aarhus Universitet Treatment protocol using intralymphatic immunotherapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0787150A1 (en) * 1994-10-25 1997-08-06 United Biomedical, Inc. SYNTHETIC IgE MEMBRANE ANCHOR PEPTIDE IMMUNOGENS FOR THE TREATMENT OF ALLERGY
US8491909B2 (en) * 2004-02-06 2013-07-23 Greer Laboratories, Inc. Methods and compositions for dosing of allergens
US20060115499A1 (en) * 2004-09-27 2006-06-01 Alk-Abello A/S Liquid allergy vaccine formulation for oromucosal administration
CN101340892A (zh) * 2005-11-04 2009-01-07 阿尔克-阿贝洛有限公司 用于口腔粘膜给药的液体变态反应性疫苗制剂的用途
CN101674845A (zh) * 2007-03-28 2010-03-17 阿尔克-阿贝洛有限公司 用于胃肠外给药的佐剂疫苗制剂的用途

Also Published As

Publication number Publication date
JP2012505856A (ja) 2012-03-08
US20110236426A1 (en) 2011-09-29
WO2010043675A1 (en) 2010-04-22
AU2009305406A1 (en) 2010-04-22
CN102186501A (zh) 2011-09-14
CA2739557A1 (en) 2010-04-22
EA201170569A1 (ru) 2011-12-30
EP2358388A1 (en) 2011-08-24
US8491911B2 (en) 2013-07-23
MX2011003752A (es) 2011-06-20

Similar Documents

Publication Publication Date Title
CY2020008I2 (el) Φαρμακοτεχνικες μορφες διστρωματικου δισκιου
DK3061445T3 (da) Højkoncentrerede farmaceutiske formuleringer
SMT201500209B (it) Forme di dosaggio farmaceutiche a rilascio controllato
BR112012011902A2 (pt) cápsula farmacêutica
DK2709667T3 (da) Bio-orthogonal lægemiddelaktivering
ZA201304709B (en) A pharmaceutical dosage form
DK2552511T3 (da) Elektromekanisk lægemiddelafgivelsesanordning
BRPI0906467A2 (pt) forma de dose farmacêutica
BR112012004314A2 (pt) compostos de ligação a il-17 e usos medicinais desses compostos
DK3028726T3 (da) Medicindispenser
DK3360575T3 (da) Transdermale farmaceutiske sammensætninger omfattende aktive stoffer
SMT201400069B (it) Formulazione farmaceutica
ZA201201712B (en) Novel pharmaceutical formulations against drug misuse
ZA200903854B (en) A gastroretentive pharmaceutical dosage form
GT201200303A (es) Formulaciones farmacéuticas
BRPI1007160A2 (pt) Método para esterilizar um material
ZA201207839B (en) Pharmaceutical composition comprising a pyrimidineone derivative
BRPI1005433A2 (pt) preparações farmacêuticas transdérmicas
CO6940426A2 (es) Formulaciones farmacéuticas
BRPI0922653A2 (pt) preparação farmacêutica
DK2437736T3 (da) Lægemiddelindgivelsessystemer
HUE038543T2 (hu) MGBG-t tartalmazó szabályozott kibocsátású orális gyógyszerészeti dózis-formák
CO7010828A2 (es) Preparación farmacéutica que comprende ߖciclodextrina sustituida
BRPI0920124A2 (pt) produto farmacêutico para aumentar a dose de vacina contra alergia
BR112013010830A2 (pt) vacina inovadoras contra o vírus da influenza pandêmica a/h1n1

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.